We are live on ! Find out more
CA

Cliff Asness AQR Capital Management

AUM $287B
1-Year Est. Return 42.33%
 

Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.

This Fund
S&P 500
This Quarter Est. Return
-12.77%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$44.2B
AUM Growth
-$8.44B
Cap. Flow
-$301M
Cap. Flow %
-0.68%
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$239M
2
MSFT icon
Microsoft
MSFT
+$204M
3
JNJ icon
Johnson & Johnson
JNJ
+$157M
4
AMZN icon
Amazon
AMZN
+$144M
5
WMT icon
Walmart Inc
WMT
+$137M

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Healthcare 16.5%
3 Financials 11.89%
4 Industrials 11.49%
5 Consumer Discretionary 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCS icon
2251
Marcus Corp
MCS
$912M
-11,179
Closed -$198K
MEC icon
2252
Mayville Engineering Co
MEC
$554M
-10,388
Closed -$97K
MELI icon
2253
Mercado Libre
MELI
$97.5B
-917
Closed -$1.09M
MFA
2254
MFA Financial
MFA
$901M
-19,914
Closed -$321K
MG icon
2255
Mistras Group
MG
$604M
-17,903
Closed -$118K
MNTS icon
2256
Momentus
MNTS
$94.7M
-1
Closed -$42K
MTRN icon
2257
Materion
MTRN
$4.83B
-3,914
Closed -$336K
NIU
2258
Niu Technologies
NIU
$153M
-62,700
Closed -$606K
ADAM
2259
Adamas Trust
ADAM
$893M
-13,107
Closed -$191K
OCGN icon
2260
Ocugen
OCGN
$471M
-48,073
Closed -$159K
IMDX
2261
Insight Molecular Diagnostics
IMDX
$142M
-676
Closed -$20K
OFLX icon
2262
Omega Flex
OFLX
$276M
-1,736
Closed -$225K
OKTA icon
2263
Okta
OKTA
$23.5B
-11,798
Closed -$1.78M
OLLI icon
2264
Ollie's Bargain Outlet
OLLI
$4.6B
-10,613
Closed -$456K
OPRX icon
2265
OptimizeRx
OPRX
$145M
-8,508
Closed -$321K
ORGN
2266
DELISTED
Origin Materials
ORGN
-394
Closed -$78K
ORMP icon
2267
Oramed Pharmaceuticals
ORMP
$200M
-17,954
Closed -$155K
OSBC icon
2268
Old Second Bancorp
OSBC
$1.29B
-11,019
Closed -$160K
PACK icon
2269
Ranpak Holdings
PACK
$436M
-26,885
Closed -$549K
PEN icon
2270
Penumbra
PEN
$12.8B
-3,017
Closed -$662K
PFG icon
2271
Principal Financial Group
PFG
$23.7B
-2,786
Closed -$205K
PI icon
2272
Impinj
PI
$5.06B
-10,649
Closed -$677K
PLNT icon
2273
Planet Fitness
PLNT
$4.09B
-22,374
Closed -$1.89M
PRTA icon
2274
Prothena Corp
PRTA
$485M
-8,363
Closed -$306K
PUBM icon
2275
PubMatic
PUBM
$747M
-7,796
Closed -$204K

Similar funds

Cliff Asness's Q2 2022 Portfolio in Review

As of Q2 2022, Cliff Asness held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Cliff Asness's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Cliff Asness's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
  • Cliff Asness added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
  • Cliff Asness's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
  • Cliff Asness fully exited Roku in Q2 2022, selling an estimated $32.5M.
  • Cliff Asness's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
  • Cliff Asness opened 150 new positions and closed 187 in Q2 2022.
  • Cliff Asness's portfolio value fell 16% quarter-over-quarter to $44.2B.

Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.